Cargando…
Transplantation, gene therapy and intestinal pathology in MNGIE patients and mice
BACKGROUND: Gastrointestinal complications are the main cause of death in patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Available treatments often restore biochemical homeostasis, but fail to cure gastrointestinal symptoms. METHODS: We evaluated the small intestine neu...
Autores principales: | Yadak, Rana, Boot, Max V., van Til, Niek P., Cazals-Hatem, Dominique, Finkenstedt, Armin, Bogaerts, Elly, de Coo, Irenaeus F., Bugiani, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194683/ https://www.ncbi.nlm.nih.gov/pubmed/30340467 http://dx.doi.org/10.1186/s12876-018-0881-0 |
Ejemplares similares
-
Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE
por: Yadak, Rana, et al.
Publicado: (2018) -
Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal
por: Yadak, Rana, et al.
Publicado: (2019) -
Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options
por: Yadak, Rana, et al.
Publicado: (2017) -
Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1)
por: Filosto, Massimiliano, et al.
Publicado: (2018) -
Pregnancy in MNGIE: a clinical and metabolic honeymoon
por: Pappalardo, Pauline, et al.
Publicado: (2020)